Jazz Pharmaceuticals and Sumitomo Pharma Announce Exclusive License Agreement to Develop and Commercialize DSP-0187, a Potent, Highly Selective Oral Orexin-2 Receptor Agonist May 4, 2022 04:05PM
Myovant Sciences Announces Closing of $400 Million Loan Facility, Repayment of Debt, Board of Director Transitions, and Executive Promotions Dec 30, 2019 08:30AM
Sumitovant Biopharma Created and Launched as Sumitomo Dainippon Pharma and Roivant Sciences Close Transaction for Strategic Alliance Dec 30, 2019 07:00AM
Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive Agreement for Strategic Alliance Oct 31, 2019 09:29AM
Myovant Sciences Enters Landmark Agreement with Sumitomo Dainippon Pharma to Secure Major Financial Backing and Safeguards for Minority Shareholders Oct 31, 2019 09:20AM


Sep 5, 2019 10:40PM Sumitomo Dainippon Pharma and Roivant Sciences Enter into a Memorandum of Understanding to Create Broad Strategic Alliance to Deliver Promising New Medicines to Patients
Jun 25, 2019 02:15AM Poxel and Sumitomo Dainippon Pharma Announce Second Positive Top-Line Results for Imeglimin Phase 3 Trial (TIMES 3) in Japan for the Treatment of Type 2 Diabetes
Aug 31, 2016 05:08PM Sunovion Pharma to Acquire Cynapsus Therapeutics (CYNA) in ~$624M Deal
Aug 31, 2016 05:07PM Sunovion Pharmaceuticals to Acquire Cynapsus Therapeutics
Feb 10, 2015 04:05PM Intercept Pharmaceuticals Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares
Feb 4, 2015 07:34PM Intercept Pharmaceuticals Announces Pricing of Public Offering